CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 838 of 865
Non-Antibody Products
Page 838 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Varinolic Acid | An analytical reference standard categorized as an intermediate in the phy… | 5 mg | 26283-5 | More Info |
| Varioxepine A | A fungal metabolite; active against F. graminearum (MIC = 4 µg / ml) | 1 mg | 32934-1 | More Info |
| Varioxepine A | A fungal metabolite; active against F. graminearum (MIC = 4 µg / ml) | 250 µg | 32934-250 | More Info |
| Varlitinib | An inhibitor of EGFR and HER2 (IC50s = 7 and 2 nM, respectively); inhibits… | 1 mg | 27651-1 | More Info |
| Varlitinib | An inhibitor of EGFR and HER2 (IC50s = 7 and 2 nM, respectively); inhibits… | 10 mg | 27651-10 | More Info |
| Varlitinib | An inhibitor of EGFR and HER2 (IC50s = 7 and 2 nM, respectively); inhibits… | 25 mg | 27651-25 | More Info |
| Varlitinib | An inhibitor of EGFR and HER2 (IC50s = 7 and 2 nM, respectively); inhibits… | 5 mg | 27651-5 | More Info |
| VAS2870 | A pan-NADPH oxidase inhibitor; pre-incubation of rat smooth muscle cells a… | 1 mg | 19205-1 | More Info |
| VAS2870 | A pan-NADPH oxidase inhibitor; pre-incubation of rat smooth muscle cells a… | 10 mg | 19205-10 | More Info |
| VAS2870 | A pan-NADPH oxidase inhibitor; pre-incubation of rat smooth muscle cells a… | 25 mg | 19205-25 | More Info |
| VAS2870 | A pan-NADPH oxidase inhibitor; pre-incubation of rat smooth muscle cells a… | 5 mg | 19205-5 | More Info |
| Vascular Eicosanoid Urinary Metabolite MaxSpec® LC-MS Mixture | Contains a collection of metabolites of vasoactive eicosanoids, including… | 1 ea | 19668-1 | More Info |
| Vasicinone | A naturally-derived alkaloid with bronchodilatory and antioxidant activity | 1 mg | 11761-1 | More Info |
| Vasicinone | A naturally-derived alkaloid with bronchodilatory and antioxidant activity | 10 mg | 11761-10 | More Info |
| Vasicinone | A naturally-derived alkaloid with bronchodilatory and antioxidant activity | 5 mg | 11761-5 | More Info |
| Vasoactive Eicosanoid HPLC Mixture | This mixture contains the characteristic metabolites of both PGI2 and TXA2… | 1 ea | 10003-1EA | More Info |
| Vatalanib (hydrochloride) | An antagonist of VEGFR1, VEGFR2, and VEGFR3 with IC50 values of 77, 37, an… | 10 mg | 14868-10 | More Info |
| Vatalanib (hydrochloride) | An antagonist of VEGFR1, VEGFR2, and VEGFR3 with IC50 values of 77, 37, an… | 100 mg | 14868-100 | More Info |
| Vatalanib (hydrochloride) | An antagonist of VEGFR1, VEGFR2, and VEGFR3 with IC50 values of 77, 37, an… | 25 mg | 14868-25 | More Info |
| Vatalanib (hydrochloride) | An antagonist of VEGFR1, VEGFR2, and VEGFR3 with IC50 values of 77, 37, an… | 50 mg | 14868-50 | More Info |
| Vatiquinone | A metabolite of α-tocotrienol that has antioxidant and ferroptosis i… | 1 mg | 26819-1 | More Info |
| Vatiquinone | A metabolite of α-tocotrienol that has antioxidant and ferroptosis i… | 10 mg | 26819-10 | More Info |
| Vatiquinone | A metabolite of α-tocotrienol that has antioxidant and ferroptosis i… | 25 mg | 26819-25 | More Info |
| Vatiquinone | A metabolite of α-tocotrienol that has antioxidant and ferroptosis i… | 5 mg | 26819-5 | More Info |
| VBIT-12 | A VDAC1 blocker; inhibits VDAC1 conductance in synthetic lipid membranes c… | 1 mg | 31445-1 | More Info |
| VBIT-12 | A VDAC1 blocker; inhibits VDAC1 conductance in synthetic lipid membranes c… | 10 mg | 31445-10 | More Info |
| VBIT-12 | A VDAC1 blocker; inhibits VDAC1 conductance in synthetic lipid membranes c… | 25 mg | 31445-25 | More Info |
| VBIT-12 | A VDAC1 blocker; inhibits VDAC1 conductance in synthetic lipid membranes c… | 5 mg | 31445-5 | More Info |
| VcMMAE | A drug-linker molecule; has been used in the synthesis of ADCs | 1 mg | 35646-1 | More Info |
| VcMMAE | A drug-linker molecule; has been used in the synthesis of ADCs | 10 mg | 35646-10 | More Info |
| VcMMAE | A drug-linker molecule; has been used in the synthesis of ADCs | 25 mg | 35646-25 | More Info |
| VcMMAE | A drug-linker molecule; has been used in the synthesis of ADCs | 5 mg | 35646-5 | More Info |
| VCP171 | A positive allosteric modulator of adenosine A1 receptors (EC50 = 15.8 &mi… | 1 mg | 30309-1 | More Info |
| VCP171 | A positive allosteric modulator of adenosine A1 receptors (EC50 = 15.8 &mi… | 10 mg | 30309-10 | More Info |
| VCP171 | A positive allosteric modulator of adenosine A1 receptors (EC50 = 15.8 &mi… | 25 mg | 30309-25 | More Info |
| VCP171 | A positive allosteric modulator of adenosine A1 receptors (EC50 = 15.8 &mi… | 5 mg | 30309-5 | More Info |
| VDM11 | An AEA transport inhibitor with essentially no activity on the CB1 recepto… | 10 mg | 10006731-10 | More Info |
| VDM11 | An AEA transport inhibitor with essentially no activity on the CB1 recepto… | 25 mg | 10006731-25 | More Info |
| VDM11 | An AEA transport inhibitor with essentially no activity on the CB1 recepto… | 5 mg | 10006731-5 | More Info |
| VDM11 | An AEA transport inhibitor with essentially no activity on the CB1 recepto… | 50 mg | 10006731-50 | More Info |
| VE-821 | An ATP-competitive inhibitor of ATR (IC50 = 26 nM); augments DNA damage an… | 1 mg | 17587-1 | More Info |
| VE-821 | An ATP-competitive inhibitor of ATR (IC50 = 26 nM); augments DNA damage an… | 10 mg | 17587-10 | More Info |
| VE-821 | An ATP-competitive inhibitor of ATR (IC50 = 26 nM); augments DNA damage an… | 5 mg | 17587-5 | More Info |
| Vecuronium (bromide) | A non-depolarizing muscle relaxant that competitively blocks cholinergic r… | 10 mg | 15603-10 | More Info |
| Vecuronium (bromide) | A non-depolarizing muscle relaxant that competitively blocks cholinergic r… | 250 mg | 15603-250 | More Info |
| Vecuronium (bromide) | A non-depolarizing muscle relaxant that competitively blocks cholinergic r… | 50 mg | 15603-50 | More Info |
| Vedaprofen | An NSAID commonly used in veterinary medicine to combat pain, inflammation… | 1 mg | 15960-1 | More Info |
| Vedaprofen | An NSAID commonly used in veterinary medicine to combat pain, inflammation… | 5 mg | 15960-5 | More Info |
| Vedaprofen | An NSAID commonly used in veterinary medicine to combat pain, inflammation… | 500 µg | 15960-500 | More Info |
| VEGF-A 164 variant (mouse, recombinant) | Source: Active recombinant mouse VEGF-A 164 variant expressed in insect ce… | 1 mg | 32068-1 | More Info |
| VEGF-A 164 variant (mouse, recombinant) | Source: Active recombinant mouse VEGF-A 164 variant expressed in insect ce… | 100 µg | 32068-100 | More Info |
| VEGF-A 164 variant (mouse, recombinant) | Source: Active recombinant mouse VEGF-A 164 variant expressed in insect ce… | 5 µg | 32068-5 | More Info |
| VEGF-C (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-C expressed in HEK293… | 1 mg | 32054-1 | More Info |
| VEGF-C (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-C expressed in HEK293… | 100 µg | 32054-100 | More Info |
| VEGF-C (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-C expressed in HEK293… | 5 µg | 32054-5 | More Info |
| VEGF-D (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-D expressed in HEK293… | 1 mg | 32055-1 | More Info |
| VEGF-D (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-D expressed in HEK293… | 10 µg | 32055-10 | More Info |
| VEGF-D (human, recombinant) | Source: Recombinant human C-terminal His-tagged VEGF-D expressed in HEK293… | 100 µg | 32055-100 | More Info |
| VEGFR3 Extracellular Domain (human, recombinant) | Source: Active recombinant human C-terminal His-tagged VEGFR3 expressed in… | 1 mg | 33746-1 | More Info |
| VEGFR3 Extracellular Domain (human, recombinant) | Source: Active recombinant human C-terminal His-tagged VEGFR3 expressed in… | 100 µg | 33746-100 | More Info |
| VEGFR2 Extracellular Domain (human, recombinant; aa 20-327) | Source: Active recombinant C-terminal human IgG1 Fc-tagged VEGFR2 expresse… | 200 µg | 31845-200 | More Info |
| VEGFR2 Kinase Inhibitor I | A potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC50 = 70 nM);… | 1 mg | 13578-1 | More Info |
| VEGFR2 Kinase Inhibitor I | A potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC50 = 70 nM);… | 10 mg | 13578-10 | More Info |
| VEGFR2 Kinase Inhibitor I | A potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC50 = 70 nM);… | 5 mg | 13578-5 | More Info |
| VEGFR2 Kinase Inhibitor I | A potent, cell-permeable inhibitor of mouse VEGFR2 kinase (IC50 = 70 nM);… | 500 µg | 13578-500 | More Info |
| VEGFR2 Kinase Inhibitor II | A reversible, cell-permeable inhibitor of VEGFR2's kinase activity (IC50 =… | 1 mg | 17544-1 | More Info |
| VEGFR2 Kinase Inhibitor II | A reversible, cell-permeable inhibitor of VEGFR2's kinase activity (IC50 =… | 5 mg | 17544-5 | More Info |
| VEGFR2 Kinase Inhibitor II | A reversible, cell-permeable inhibitor of VEGFR2's kinase activity (IC50 =… | 500 µg | 17544-500 | More Info |
| VEGFR Tyrosine Kinase Inhibitor II | Inhibits the kinase activities of VEGFR2 (KDR), VEGFR1 (FLT1), and c-Kit (… | 1 mg | 17654-1 | More Info |
| VEGFR Tyrosine Kinase Inhibitor II | Inhibits the kinase activities of VEGFR2 (KDR), VEGFR1 (FLT1), and c-Kit (… | 5 mg | 17654-5 | More Info |
| Velaresol | An Hb-O2 stabilizer; increases erythrocyte deformability in isolated human… | 10 mg | 37190-10 | More Info |
| Velaresol | An Hb-O2 stabilizer; increases erythrocyte deformability in isolated human… | 25 mg | 37190-25 | More Info |
| Velaresol | An Hb-O2 stabilizer; increases erythrocyte deformability in isolated human… | 5 mg | 37190-5 | More Info |
| Velaresol | An Hb-O2 stabilizer; increases erythrocyte deformability in isolated human… | 50 mg | 37190-50 | More Info |
| Velneperit | An antagonist of NPY receptor Y5 (Ki = 5.3 nM); selective for Y5 over Y1,… | 1 mg | 33850-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile